VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,005,309 | -11.3% | 111,680 | -0.8% | 3.53% | -6.9% |
| Q2 2023 | $3,389,151 | -7.0% | 112,559 | -0.1% | 3.79% | -11.1% |
| Q1 2023 | $3,645,683 | +10.3% | 112,695 | -2.2% | 4.27% | +3.7% |
| Q4 2022 | $3,303,982 | +15.5% | 115,282 | -2.8% | 4.12% | +1.2% |
| Q3 2022 | $2,860,000 | -14.5% | 118,562 | -3.0% | 4.07% | -5.9% |
| Q2 2022 | $3,346,000 | +61.2% | 122,206 | +125.7% | 4.32% | +76.0% |
| Q1 2022 | $2,076,000 | +13.8% | 54,135 | -5.0% | 2.46% | +60.4% |
| Q4 2021 | $1,825,000 | -46.7% | 56,983 | -50.9% | 1.53% | -46.0% |
| Q3 2021 | $3,421,000 | -12.6% | 116,096 | +0.8% | 2.84% | -6.2% |
| Q2 2021 | $3,914,000 | +4.2% | 115,190 | -0.3% | 3.02% | -8.6% |
| Q1 2021 | $3,756,000 | -11.7% | 115,573 | -2.1% | 3.31% | -10.1% |
| Q4 2020 | $4,253,000 | -11.8% | 118,066 | -0.1% | 3.68% | -15.0% |
| Q3 2020 | $4,821,000 | +12.2% | 118,217 | +1.0% | 4.33% | +1.0% |
| Q2 2020 | $4,295,000 | +53.8% | 117,098 | -3.4% | 4.29% | +9.1% |
| Q1 2020 | $2,792,000 | -27.7% | 121,185 | -8.1% | 3.93% | +7.9% |
| Q4 2019 | $3,860,000 | +4.4% | 131,846 | -4.8% | 3.64% | -16.1% |
| Q3 2019 | $3,699,000 | +158.1% | 138,490 | +147.1% | 4.34% | +153.9% |
| Q2 2019 | $1,433,000 | +11.8% | 56,055 | -2.0% | 1.71% | -0.1% |
| Q1 2019 | $1,282,000 | +3.6% | 57,180 | -2.6% | 1.71% | -28.0% |
| Q4 2018 | $1,238,000 | +3.1% | 58,720 | -9.4% | 2.38% | +97.0% |
| Q3 2018 | $1,201,000 | -18.7% | 64,830 | -2.1% | 1.21% | -22.1% |
| Q2 2018 | $1,478,000 | +19.7% | 66,235 | +17.9% | 1.55% | +9.5% |
| Q1 2018 | $1,235,000 | +209.5% | 56,185 | +226.9% | 1.42% | +213.3% |
| Q4 2017 | $399,000 | -5.9% | 17,185 | -7.0% | 0.45% | -10.0% |
| Q3 2017 | $424,000 | -99.9% | 18,475 | +14.0% | 0.50% | +22.4% |
| Q2 2017 | $357,696,000 | -4.8% | 16,200 | -1.7% | 0.41% | -11.8% |
| Q1 2017 | $375,795,000 | – | 16,475 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |